Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J Declines to Comment on U.S. Approval of Sanofi Deal
Bloomberg
Thursday, December 27, 2012 - 10:09pm
tags:
JNJ, Sanofi, antitrust
Does Lilly's Lineup Make the Grade?
Motley Fool
Thursday, December 27, 2012 - 10:08pm
tags:
Eli Lilly
Is Celgene in Good Hands?
Motley Fool
Thursday, December 27, 2012 - 7:59am
tags:
Celgene
3 Drug Disappointments From 2012
Motley Fool
Wednesday, December 26, 2012 - 9:33pm
tags:
Zaltrap, Sanofi, Amarin, Vascepa, Qsymia, Arena Pharmaceuticals
A Comprehensive Analysis Of NPS Pharmaceuticals
Seeking Alpha
Wednesday, December 26, 2012 - 9:29pm
tags:
NPS Pharmaceuticals
Key Dates For Arena And Orexigen Investors
Seeking Alpha
Wednesday, December 26, 2012 - 9:25pm
tags:
Orexigen, Contrave, Belviq, Arena Pharmaceuticals, Qsymia, Vivus, obesity
Actelion Drug to Move into Phase III
Yahoo/Zacks
Wednesday, December 26, 2012 - 9:24pm
tags:
Actelion, cadazolid, Clostridium Difficile
Depomed Announces Dismissal Of Suit Against Two Gralise ANDA Filers Following Withdrawal Of ANDA And Patent Challenge
Yahoo
Wednesday, December 26, 2012 - 9:23pm
tags:
Gralise, Depomed
This Beaten Down Drug Company Can Provide Value in 2013
Motley Fool
Wednesday, December 26, 2012 - 9:22pm
tags:
Merck
Several Reasons Why I'm Considering These 2 Biotech Firms Before Year's End
Seeking Alpha
Wednesday, December 26, 2012 - 9:21pm
tags:
Raptor Pharmaceuticals, Aegerion
Ironwood commences first phase of anxiety drug trial in US
Pharmaceutical Business Review
Wednesday, December 26, 2012 - 12:05pm
tags:
Ironwood Pharmaceuticals, anxiety, IW-2143
Bristol-Myers, Pfizer's Eliquis approved in Japan
Yahoo/AP
Wednesday, December 26, 2012 - 12:02pm
tags:
Pfizer, Japan, Bristol-Myers Squibb
Acadia Pharma says it raised a total of $173M through sale of 11.6M shares
Yahoo/AP
Wednesday, December 26, 2012 - 9:33am
tags:
Acadia, stock offering
4 FDA Approvals in 1 Day
Motley Fool
Wednesday, December 26, 2012 - 9:30am
tags:
FDA, drug approvals, Roche, Tamiflu, Gilead Sciences, Gattex, NPS Pharmaceuticals, Alexza, Adasuve, VariZIG, Cangene
Investments In Novel IL-12 Adminstration Platforms In The Fight Against Cancer
Seeking Alpha
Wednesday, December 26, 2012 - 9:27am
tags:
Merck, OncoSec, Ziopharm, Interleukin-12
Rejection of InterMune’s Drug Told Early to FDA Advisers
Bloomberg
Wednesday, December 26, 2012 - 9:23am
tags:
FDA, InterMune, Esbriet, IPF
4 Small Biotech Stocks That Should Continue With Large Returns In 2013
Seeking Alpha
Wednesday, December 26, 2012 - 9:21am
tags:
Celldex, Galena Biopharma, NewLink Genetics, Sunesis
US FDA grants fast track status to Lexicon's LX1033
Pharmaceutical Business Review
Monday, December 24, 2012 - 10:55am
tags:
FDA, Lexicon Pharmaceuticals, LX1033, D-IBS
Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma
Equities.com
Monday, December 24, 2012 - 10:53am
tags:
Infinity Pharmaceuticals, P13K-Delta, Millennium
1 Reason ViroPharma May Be Headed for a Slowdown
Motley Fool
Monday, December 24, 2012 - 10:50am
tags:
ViroPharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.